SynthesisUrolithiasis2026
Where does endogenous oxalate come from? - a systematic review of endogenous sources of urinary oxalate.
Synthesis in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic origins of hyperoxaluria: the critical role of precursors and vitamin B6 status in rats.Urolithiasis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxalate is a toxic waste product in humans, capable of complexing with calcium to form kidney stones. While some oxalate is consumed in the diet, there are endogenous sources in humans. This review compiles known endogenous sources of urinary oxalate. PubMed and Embase databases were searched, as well as backward citations, for relevant articles published in English. The search strategy relied on terms related to endogenous synthesis and metabolic tracing. Title/abstract review was performed, and articles were excluded from full review if they did not report data on human sources of endogenous oxalate. Risk of bias was assessed using a modified JBI checklist. Weighted averaging was used to combine results and predict endogenous oxalate production. Of 228 unique articles identified, 23 were eligible and included in this study. Total endogenous oxalate production was reported by 7 of the papers, representing 305 healthy subjects. Weighted mean of endogenous oxalate production was 23.8 mg/day (95% CI 23-24.6 mg/day) with a range of 17-34 mg/day. Daily turnover from the metabolic pool of ascorbic acid may account for up to 40% - 60% of total endogenous oxalate production. Other contributors include hydroxyproline (~ 15%), glycine (< 10%), and glycolate (~ 4%). Phenylalanine (< 0.7%), and fructose (negligible) contribute minimally. This review highlights that daily turnover from the metabolic pool of ascorbic acid is the primary source of endogenous oxalate. However, current estimates rely on highly variable data dating back nearly 70 years. Future research using modern metabolomics is required to re-characterize this pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.